Last Friday (26th of July 2019) one of the most recent clinical trials involving ReOxy has been registered with database with NCT04034082 identifier.

This randomised controlled pilot study led by Prof. Roberto FE Pedretti, MD (Istituti Clinici Scientifici Maugeri SpA, Pavia, Italy) aimed at evaluation of the efficacy of Interval Hypoxic Hyperoxic Treatment in cardiac rehabilitation of elderly patients. The study has started on 12th of February 2019 and is planned to enrol 30 participants into two groups during the initial term of 1 year.

Ai Mediq S.A. in cooperation with our Italian partner Ver San & Dafne m.d. Srl is more than willing to continuously support this clinical trial and will be looking forward to the outcomes in early 2020.

More details can be found on the relevant page linked below.